Tryg A/S
Statement of transactions by members of senior management and their related parties in shares, issued by Tryg and related securities, cf. article 19 of the EU Regulation 596/2014.
A member of the Supervisory Board has carried out a transaction in connection with Tryg's rights issue, see https://tryg.com/en/emission
| 1. | Details of the person discharging managerial responsibilities/person closely associated | |
| a) | Name | Carl-Viggo Östlund |
| 2. | Reason for notification | |
| a) | Position/status | Board Member |
| b) | Initial notification/ amendment | Initial notification |
| 3. | Details of the issuer | |
| a) | Name | Tryg A/S |
| b) | LEI | 213800ZRS8AC4LSTCE39 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument Identification code | Shares (subscription rights) DK0061534534 |
| b) | Name of transaction | Sale of subscription rights in connection with rights issue |
| c) | Price(s) and volume(s) | Price(s): DKK 6.8726 Volume(s): 5 subscription rights |
| d) | Aggregated information
| 5 subscription rights DKK 34.36 |
| e) | Date of transaction | 2021-03-15 |
| f) | Place of transaction | NASDAQ Copenhagen A/S (XCSE) |
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
ALK Abello19.12.2025 22:46:46 CET | Press release
Major shareholder announcement
ALK Abello19.12.2025 22:46:46 CET | Pressemeddelelse
Storaktionærmeddelelse
Zealand Pharma19.12.2025 22:00:00 CET | Press release
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Boehringer Ingelheim Limited19.12.2025 21:10:00 CET | Press release
U.S. FDA approves JASCAYD® (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults
Novartis Pharma AG19.12.2025 20:30:06 CET | Press release
Novartis and US government reach agreement on lowering drug prices in the US
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
